U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455864) titled 'Lysosomal Acid Lipase Deficiency in Risk Groups' on March 03.
Brief Summary: A multicenter real-world observational study of the prevalence, diagnostic pathways, and clinical characteristics of lysosomal acid lipase deficiency in pediatric and adolescent risk groups in the Russian Federation (HELIOS)
Study Start Date: Feb. 25
Study Type: OBSERVATIONAL
Condition:
Lysosomal Acid Lipase Deficiency
Recruitment Status: RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....